Biocon Ltd on Monday said its board has approved raising Rs 570 crore through issuance of commercial papers on private ...

Biocon share price gained 2.61 per cent at Rs 398 a piece on the BSE in Thursday’s intraday trade. This came after the ...

Bengaluru: Biocon Limited, a global biopharmaceuticals company, has announced its Environmental, Social and Governance (ESG) ...

SMC Global Securities said that Eicher Motors has been trading within a well-defined channel, and a breakout has occurred on ...

India should eliminate tax on drugs for cancer treatment and for chronic and rare diseases, the chairperson of major ...

Bajaj Finserv Ltd. has garnered multiple buy recommendations from various analysts, all predicting an upward movement in the ...

Biocon Ltd has approved raising Rs 570 crore through issuance of commercial papers on private placement basis. The company also reported an improvement in its ESG scores.

CCI fines Goldman Sachs for undisclosed investment in Biocon, highlighting need for compliance with competition laws in ...

The market is expected to sustain range-bound trading, and the elevated volatility signals caution for bulls. Below are some ...

The Competition Commission of India fined Goldman Sachs AIMPL Rs 40 lakh for not notifying it about a deal that included ...

Biocon in its Environmental, Social and Governance (ESG) scores as assessed by S&P Global’s Corporate Sustainability Assessment (CSA) for 2024 has achieved an improvement to 69 in 2024, up 6 points ...

HYDERABAD, India (Reuters) - India should eliminate tax on drugs for cancer treatment and for chronic and rare diseases, the chairperson of major drugmaker Biocon Ltd said ahead of Prime Minister ...